voice problems after total thyroidectomy. Speech disturbances, not elsewhere classified
Conditions
Interventions
Intervention 1: Intervention group A: rosuvastatin (Ropixon Abidipharm) tab 20 mg Q12hr plus calcitriol (Daanapharm) cap 0.25 mcg Q12hr for two weeks prior to surgery. Intervention 2: Intervention gro
Sponsors
Shiraz University of Medical Sciences
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: All the patients who visited a thyroid clinic and a referral establishment in southwest Iran (Shiraz) age above 18 are due to undergone total thyroidectomy
Exclusion criteria
Exclusion criteria: patients who routinely use anti-inflammatory drugs (such as steroids), statins, or calcitriol patients who undergone partial thyroidectomy patients who undergone radical or lateral nuchal lymph-node dissection patients who refuse to participate in the study death of the patient patients who underwent previous nuchal surgeries patients who experience direct injury to the laryngeal nerves either during the surgery or during the thyroid biopsy procedure patients with underlying condition that directly affected their vocal functions (such as neurological conditions)
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Voice handicap index (VHI) score. Timepoint: one month after surgery. Method of measurement: voice handicap index questionnaire. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactMohammad Reza Yousefi
Shiraz University of Medical Sciences
Outcome results
None listed